beta-alanine has been researched along with Fatty Liver, Nonalcoholic in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of obesity and metabolic syndrome." | 5.40 | Thrombin inhibition with dabigatran protects against high-fat diet-induced fatty liver disease in mice. ( Flick, MJ; Joshi, N; Kassel, KM; Kopec, AK; Luyendyk, JP; Sullivan, BP; Towery, KL, 2014) |
| "Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of obesity and metabolic syndrome." | 1.40 | Thrombin inhibition with dabigatran protects against high-fat diet-induced fatty liver disease in mice. ( Flick, MJ; Joshi, N; Kassel, KM; Kopec, AK; Luyendyk, JP; Sullivan, BP; Towery, KL, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kopec, AK | 1 |
| Joshi, N | 1 |
| Towery, KL | 1 |
| Kassel, KM | 1 |
| Sullivan, BP | 1 |
| Flick, MJ | 1 |
| Luyendyk, JP | 1 |
1 other study available for beta-alanine and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Thrombin inhibition with dabigatran protects against high-fat diet-induced fatty liver disease in mice.
Topics: Alanine Transaminase; Animals; Benzimidazoles; beta-Alanine; Bile Acids and Salts; Dabigatran; Diet, | 2014 |